Fluenz Tetra
PreclinicalBiologic
Fluenz Tetra is one of 3 biologic programs targeting Vaccines. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
4 competitors in Vaccines
#DrugCompanyPhaseTrials
1BCG Vaccine
GGynecologic Oncology Group
Phase 3
Measles Vaccine
GSKPhase 3
Fluenz Tetra
PPublic Health England
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Fluenz Tetra. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- PPublic Health England